A phase II study of omacetaxine mepesuccinate for patients...

  • Main
  • 2018 / 10
  • A phase II study of omacetaxine mepesuccinate for patients...

A phase II study of omacetaxine mepesuccinate for patients with higher-risk myelodysplastic syndrome and chronic myelomonocytic leukemia after failure of hypomethylating agents

Short, Nicholas J., Jabbour, Elias, Naqvi, Kiran, Patel, Ami, Ning, Jing, Sasaki, Koji, Nogueras-Gonzalez, Graciela M., Bose, Prithviraj, Kornblau, Steven M., Takahashi, Koichi, Andreeff, Michael, San
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
American Journal of Hematology
DOI:
10.1002/ajh.25318
Date:
October, 2018
File:
PDF, 2.19 MB
english, 2018
Conversion to is in progress
Conversion to is failed